|May 09, 2011|
Berkley Resources Announces Update On Life Sciences Investment
|TrichoScience Innovations Inc. Purchased by Newcastle Resources|
VANCOUVER - Berkley Resources Inc. ("Berkley") announces that TrichoScience Innovations Inc. ("TrichoScience"), of which Berkley previously held 400,000 common shares, was purchased 100% by Newcastle Resources Ltd. (Newcastle). Under a corresponding Share Exchange Agreement between TrichoScience and Newcastle, Berkley's holdings were converted to 937,686 Newcastle shares.
Newcastle Changing Name to RepliCel Life Sciences
On May 4, 2011, Newcastle announced it is now doing business under the name Replicel Life Sciences ("RepliCel") (OTCQB: NCSLF). RepliCel is developing a cell-based procedure for the treatment of androgenetic alopecia, also known as pattern baldness and general hair loss in men and women. The company intends to formally change its legal name in due course.
About RepliCel Life Sciences
RepliCel Life Sciences has developed RepliCel(tm), a natural hair cell replication technology that has the potential to become the world's first, minimally invasive solution for androgenetic alopecia and general hair loss in both men and women. RepliCel(tm) is based on autologous cell implantation technology that replicates a patient's hair cells from their own healthy hair follicles and, when reintroduced into areas of hair loss, the company hopes to initiate natural hair regeneration. Patents for the technology have been issued by the European Union and Australia and are pending in other major international jurisdictions. The RepliCel(tm) procedure has been developed over the past nine years by the Company's recognized research scientists and medical experts - specialists in the fields of hair growth, hair biology and dermatology.
New RepliCel Website
RepliCel is pleased to announce the launch of its new corporate website located at www.replicel.com. The new site provides visitors with a comprehensive source of information on the company's hair replacement technology and first-in-human clinical trial. On the home page, viewers can access a 3-D video animation explaining the mechanics and science behind the Replicel(tm) procedure. The website also provides information about the history of the company and its medical and scientific team.
ON BEHALF OF THE BOARD:
President & CEO, Berkley Resources Ltd.
ABOUT BERKLEY RESOURCES INC.
Berkley is a growth-oriented and diversified energy and venture company pursuing opportunities in both Canada and the United States. The company's shares trade on the Canadian National Stock Exchange (CNSX) under the symbol BKS and in the U.S. under the symbol BRKDF.
For more information visit: www.berkleyresources.com.
ON BEHALF OF THE BOARD
President and Chief Executive Officer
604 682 3701
You can view the Next News Releases item: Fri Apr 13, 2012, Berkley Resources Completes Share Consolidation And Name Change
You can view the Previous News Releases item: Tue Mar 15, 2011, Berkley Resources Launches Renewable Energy Initiative
You can return to the main News Releases page, or press the Back button on your browser.